Stephen Galli
Director/Board Member bij ATOSSA THERAPEUTICS, INC.
Vermogen: 178 $ op 31-03-2024
Profiel
Stephen J.
Galli is an Independent Director at Atossa Therapeutics, Inc., a Professor at Stanford University School of Medicine, and the President of the Association of Pathology Chairs.
He was formerly the President of the Collegium Internationale Allergologicum and the American Society for Investigative Pathology.
Galli received his doctorate from Harvard Medical School in 1973 and his undergraduate degree from Harvard College in 1968.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
15-03-2024 | 99 ( 0.00% ) | 178 $ | 31-03-2024 |
Actieve functies van Stephen Galli
Bedrijven | Functie | Begin |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Director/Board Member | 01-07-2011 |
Stanford University School of Medicine | Corporate Officer/Principal | 01-02-1999 |
Association of Pathology Chairs | President | - |
Eerdere bekende functies van Stephen Galli
Bedrijven | Functie | Einde |
---|---|---|
Collegium Internationale Allergologicum | President | - |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | President | - |
Opleiding van Stephen Galli
Harvard Medical School | Doctorate Degree |
Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Collegium Internationale Allergologicum | |
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
Association of Pathology Chairs |